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INTRODUCTION
Reports from different parts of the world show differences in the pattern of maxillofacial tumors seen. [1] Tumors may arise from any part of the tissues, both soft and hard and spread to involve the surrounding tissues. Rate of growth depend on the nature of the lesion which include hamartomas, benign and malignant tumours. [ 2] Some of the lesions are observed in a particular age group and are 43 more prevalent in one gender than the other and also present different which the statistics differ in different studies. [3] These neoplasms affect speech and deglutition due to their special location and might result in expansion, tooth mobility and destruction of adjacent structures. [4] Location and histologic types of these lesions can be valuable in clinical diagnosis and patient's management. These neoplasms have peculiar importance and their incidence has been detailed in various countries. [5, 6] Few studies have addressed the epidemiology of the orofacial neoplasms, and most of the researches in the different parts of the world have focused on a specific type of oral lesions such as squamous cell carcinoma. [7] There have been reports on the prevalence of orofacial neoplasms in different parts of the world with Salvin and Cameron reporting ameloblastoma to be the commonest in Uganda and Tanzania, [8] while Burkitt's lymphoma was reported as the commonest in Kenya. [9] Some of the lesions are observed in a particular age group and are more prevalent in one gender than the other with different study statistics. [10] [11] [12] Reports of orofacial neoplasms from Nigeria have mainly been from the northern and southwestern regions. [13] These Nigerian studies found squamous cell carcinoma (66.7%) as the most prevalent malignant lesion and ameloblastoma (14.02%) as the second most predominant benign orofacial tumors. The Maxillofacial unit in the UUTH is relatively new and no previous study on the pattern of presentation of orofacial neoplasms has been carried out.
The aim of this study was to document the pattern of presentation which include the age, site of distribution and histologic types of orofacial tumors seen in our center in the past 2 years and to compare the findings with previous studies in the literature.
METHODOLOGY
This study was carried out using the biopsy information of all patients with orofacial neoplasms sent to the Pathology department of University of Uyo Teaching Hospital. The biopsy results of all consecutive patients who presented with oral and maxillofacial neoplasms to the maxillofacial unit of University of Uyo Teaching Hospital between December 2011 and November 2013 were retrospectively analyzed. A total of 186 orofacial neoplastic cases were seen within the period of study. The parameters for the study included socio-demographics, site of the lesion, clinical characteristics and histopathologic diagnosis. The anatomical sites of lesions were determined for all the specimens, and the lesions were divided into two types, according to the pathology report; benign and malignant tumors.
The site of the neoplasm was recorded. The lip included both lower and upper while the palate included hard and soft palate and oropharyngeal parts. Other sites recorded included gingiva, floor of the mouth, parotid region, maxilla and mandibular bones.
Inclusion/exclusion criteria
Fine needle aspiration cytology, non-neoplastic cysts and inflammatory lesions as well as those with no final histological diagnoses were excluded from the study.
Ethical consideration
The study was performed according to the ethical guidelines for research involving human subjects and ethical clearance obtained from the hospital's ethics committee. Informed consent was obtained from each patient.
Data analysis
Data obtained were documented, analyzed and expressed as simple frequencies and proportions with SPSS package version 16 and Microsoft Excel spread sheet after they were scrutinised and cleaned.
RESULTS
A total of 186 orofacial neoplastic cases were seen within the period of study. Benign lesions accounted for 112 (60.21%), while 74 (39.79%) of the cases were malignant lesions. Of the retrieved cases, 71(38%) were males and 115(62%) were females giving a male to female ratio of 1:1.5 as shown in figure 1 . We recorded 95 (51.08%) cases from rural settlers while 91 (48.92%) were urban settlers. Table 1 shows age distribution of the study group. The overall average age was 29.29 ± 19.72 with a range of 0-80 years. Greater percentage of the cases were within the fifth decade (41.92%), closely followed by the fourth decade of life (38.71%). Table 2 shows the occupational distribution of the subjects. Farmers were found to be the most affected group while students were the least affected. We also recorded the highest number of neoplastic lesions among the married 62 (33.33%) followed by singles 51 (27.42) and widow/widower (16.13%) as shown in table 3. Table 4 shows that in the malignant category, squamous cell carcinoma was the commonest (32.43%) followed by fibrosarcoma (20.27%) and non-Hodgkin lymphoma (15.14%). Among the benign neoplasms, ameloblastoma (18.75%), ossifying fibroma (16.08%) and fibrous dysplasia (13.39%) were the most frequent.
The distribution of the tumours according to age is shown in table 5. The neoplasms showed a statistically significant (X 2 =275.271, df= 133, P=0.001) wide range of age distribution with most neoplasms. The age of occurrence of benign odontogenic tumour like ameloblastoma were the 3rd-5th decades with a peak in the 3rd decade of life. For the malignant lesion, typified by squamous cell carcinoma, the ages of occurrence ranged from 4th-7th decades with peak age spread across the 5th to 6th decades. In addition, paediatric jaw tumour like Burkitt's lymphoma occurred predominantly in the 1st decade (table 5 ).
The site distribution of some selected neoplasms is as summarized in table 6. The neoplasms had different site predilections and the distribution was significant (X 2 =124.146, df=133, P=0.001). Ameloblastoma was found more in the mandible, while ossifying fibroma and fibrous dysplasia was found more in the maxilla. Table 7 shows the gender distribution of the neoplasms. In line with gender distribution as shown in figure 1, more females were affected (X 2 =9.252, df=19, P=0.969).
DISCUSSION
The present study evaluated oral and maxillofacial neoplasm in a new surgical unit. The male to female ratio of 1:1.5 in this study contrasts with the 1:1 to 2.3:1 reported by Lilly-Tariah et al. [13] where a review published articles on head and neck cancers in Nigeria from 1968 to 2008 was undertaken. In addition, the observed gender ratio in the present study also differ from the 1.7:1 obtained in a six year review by Abuidris et al. [14] from central Sudan and the 2.4:1 ratio in a 13 year Japanese study. [15] These studies indicated higher occurrence in males contrary to the observation from the present study, which support a female preponderance. This is probably because females tend to show more concern about their appearance, hence they report more to the clinic. The overall age range was 0-80 years in this study is in agreement with the analysis of related Nigerian studies where a range of 9 months to over 80 years was reported. [13] In contrast with study by Thorakkal, [16] the most common age for the incidence of neoplastic lesions was 41 to 50 years in our study. More of the farmers (25%) and the married (33%) were affected. There is no available previous similar study to compare these findings. In this study, malignant maxillofacial neoplasms accounted for up to 39.78%, a figure that is similar to other reports. [17] [18] [19] This was higher than studies from Ajayi et al. in Lagos, southwest Nigeria; 18%, Chidzonga study in Zimbabwe; 24.8%; but lower than that reported by Parkins et al. in Ghana; 59%. [20] [21] [22] In this study, squamous cell carcinoma was found to be the most prevalent of the malignant variable, while ameloblastoma was found to be the most prevalent of benign tumors. The commonest malignancy was squamous cell carcinoma accounting for 32.43%. This was in agreement with other studies that reported squamous cell carcinoma as the most frequent malignancy. [17, 18, 23] A higher proportion of 41% was reported by a study conducted in Libya, [24] while Abdulai et al. in a study in Ghana also reported squamous cell carcinoma as the most prevalent (45.6%). [25] Interestingly, oral squamous cell carcinoma constituted a much higher proportion of oral malignancies in a study in Jordan (84%), [26] and Pakistan (92.2%). [27] Fibrosarcoma was the second most frequent malignant lesion found in this study which is different from the results of other studies that found salivary gland tumours ranking below squamous cell carcinoma. [28, 29] Of the sarcomas, fibrosarcoma was the commonest histologic subtype in this study. However, Chindzonga reported kaposi sarcoma as the commonest in the series of sarcomas in his study. [28] Whereas Aregbesola et al. [30] reported osteosarcoma as the commonest in the sarcomatous series, Bhatia et al. reported it as a very rare tumor. [31] 
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Lymphomas accounted for 17.57% of all malignant tumours in the orofacial region in this study. This was higher than the 14% recorded for lymphomas in some reports in the literature. [22, 29] Non-Hodgkins lymphoma accounted for 69.23% of all lymphomas with Burkitt's lymphoma constituting 30.77% of lymphomas and 4% of all orofacial malignancies. These findings differ from those recorded by other studies in the literature where Burkitt's lymphoma accounted for 53% of orofacial malignancies. [22, 28] Non Hodgkin's lymphoma was reported by Jones et al. [19] as the second commonest malignancy in their study whereas it is ranked third malignancy in the current study.
In this study, salivary gland neoplasia accounted for about 14%. This is higher than figures reported from Europe. [19] In the malignant salivary gland neoplasms, mucoepidermoid carcinoma was the only neoplasm recorded and this accounted for 7% of the malignant cases. This differs from the study by Jones et al. who recorded other malignant variants of salivary gland tumors with adenocarcinoma being the commonest. [19] Benign neoplasms constituted 60.22% of the entire spectrum of maxillofacial tumours seen over the study period. Ameloblastoma was the most prevalent benign tumor in the present research with 21 cases (18.75%), which is similar to some studies, [ 8] but disagrees with some. [32] However, this figure is in contrast with other African and Chinese studies where figures as high as 84% of ameloblastoma were recorded. [19, 33] The lower frequency of ameloblastoma in our study may be due to patronage of non-orthodox medicine since the tumour is slow growing. Because of ignorance, faith in native healers, reluctance of some patients to seek medical or dental care, and limited facilities, many patients from rural areas still delay seeking hospital treatment until very late. [34] In the present series, 95 cases (51.08%) presented from the rural areas while 91 (48.92%) were from the urban area.
Almost all the demographics in our study disagreed with previous reports. In this study, ameloblastoma, ossifying fibroma, fibrous dysplasia, odontoma and osteoma were the commonest in descending order. This differs from the report by Jones et al. [19] in which papillomas then pleomorphic adenomas were ranked as first and second. Only one case of lipoma was documented in the mouth. This is in agreement with a previous study by Omisakin and Ajike who reported that lipomas of oral origin are rare compared to other parts of the body. [35] The relative frequency of tumours at diffierent sites varies widely in reports from different countries. A comparison tabulated by Smith [36] shows how different oral sites predominate in four widely separate populations, the widest disparity being evident in figures of lip cancer. In a study by Daramola et al. [37] in Ibadan, the tongue was the commonest site, whereas in the present study, no lesion was found on the tongue while the commonest site of lesions was the mandible. The commonest site for the benign lesions was found to be mandible for the bony lesions and lip for the soft tissue lesions. More of the malignant lesions were in oral mucosa as against lip as recorded in previous study. All four cases recorded for Burkitt's lymphoma in the present study were seen in the maxilla. This is in agreement with Aregbesola et al. [30] who reported that Burkitt's lymphoma predominantly occurred in the maxilla. Burkitt's lymphoma is usually found in childhood and the maxilla is the single most common initial site. [38] The palate was the most common intraoral site (19 cases) followed by the lip. This is in agreement with findings by Lawoyin et al., [39] in a study in Ibadan, who reported that the palate was the most common site, but differs from the report by Odukoya et al. from Lagos where the gingiva was the commonest site intraorally. [40] Also, in contrast to the present study, a study by Ugboko et al. [41] in Ile-Ife, Nigeria reported the alveolus as the most common intraoral site. In the present study, intraorally, the highest lesion recorded on the lip was pyogenic granuloma. In contrast to this, Abdulai et al. reported pyogenic granuloma to be most prevalent on the gingiva. [42] 
CONCLUSION
In conclusion, we presented a report of orofacial tumors with a high prevalence of benign tumors than the malignant tumors. Benign lesion accounted for 112 (60.21%) while malignant lesions were 74(39.79%). Squamous cell carcinoma (32.43%) was the most prevalent malignant variant while ameloblastoma was found to be the most prevalent of the benign group. More females (62%) were affected with male:female ratio of 1:1.5. This may be due to geographic peculiarity of the study area where females tend to show more concern about their appearance, hence they report more to the clinic. This study further showed an insight into the prevalence of neoplastic conditions. Recorded orofacial neoplasms from this study were different from reports by other authors. The result however, simply reflects the frequency of histologically diagnosed neoplasms. It does appear that the benign oral and jaw lesions is more prevalent in this study area. It is important to carry out this type of study periodically to know the current trends of occurrence and susceptible group.
